Ketamine in Substance Use Disorder Treatment: A Narrative Review.

Alpha Psychiatry

Department of Psychiatry, Medical University of Silesia, Faculty of Medical Sciences, Zabrze, Poland.

Published: March 2024

AI Article Synopsis

  • Substance use disorder (SUD) is a major global health issue, and ketamine is being explored as a new treatment option due to its anesthetic and potential therapeutic properties.
  • The review highlights how ketamine affects the brain, particularly its influence on neurotransmission and pathways related to reward and neuroplasticity, which could be beneficial for those dealing with substance abuse.
  • The article emphasizes the importance of further research on ketamine's psychotropic and dissociative effects to improve treatment outcomes for SUD and advance personalized medicine in addiction.

Article Abstract

Substance use disorder (SUD) continues to pose a significant global health challenge, necessitating innovative and effective therapeutic interventions. Ketamine, traditionally recognized for its anesthetic properties, has emerged as a novel and promising avenue for the treatment of SUD. This narrative review critically examines the current body of literature surrounding the use of ketamine in various forms and settings for individuals grappling with substance abuse. The review explores the neurobiological underpinnings of ketamine's potential therapeutic effects in SUD, shedding light on its impact on glutamatergic neurotransmission, neuroplasticity, and reward pathways. Special attention is given to the psychotropic and dissociative properties of ketamine, exploring their implications for both therapeutic outcomes and patient experience. Ultimately, this review aims to provide a comprehensive overview of the current state of knowledge regarding ketamine's role in the treatment of SUD, emphasizing the need for further research and clinical exploration. As we navigate the complex terrain of addiction medicine, understanding the nuances of ketamine's potential in SUD holds promise for the development of more effective and personalized therapeutic strategies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11117434PMC
http://dx.doi.org/10.5152/alphapsychiatry.2024.241522DOI Listing

Publication Analysis

Top Keywords

substance disorder
8
narrative review
8
treatment sud
8
ketamine's potential
8
sud
5
ketamine
4
ketamine substance
4
disorder treatment
4
treatment narrative
4
review
4

Similar Publications

: Recovery management checkups done in primary care settings (RMC-PCs) can be an effective intervention to link individuals with substance use disorders (SUD) to treatment and help them stay engaged with treatment. There is reason to question, however, whether RMC-PCs are as effective for those who have been recently incarcerated or for those holding a minoritized, racial identity. : We examined data from a randomized controlled trial of RMC-PCs compared to a control condition ( = 266).

View Article and Find Full Text PDF

Plants recognize a variety of environmental molecules, thereby triggering appropriate responses to biotic or abiotic stresses. Substances containing microbes-associated molecular patterns (MAMPs) and damage-associated molecular patterns (DAMPs) are representative inducers of pathogen resistance and damage repair, thus treatment of healthy plants with such substances can pre-activate plant immunity and cell repair functions. In this study, the effects of DAMP/MAMP oligosaccharides mixture (Oligo-Mix) derived from plant cell wall (cello-oligosaccharide and xylo-oligosaccharide), and fungal cell wall (chitin-oligosaccharide) were examined in cucumber.

View Article and Find Full Text PDF

Glucagon-like peptide-1 receptor agonists (GLP1RAs) effectively reduce body weight and improve metabolic outcomes, yet established peptide-based therapies require injections and complex manufacturing. Small-molecule GLP1RAs promise oral bioavailability and scalable manufacturing, but their selective binding to human versus rodent receptors has limited mechanistic studies. The neural circuits through which these emerging therapeutics modulate feeding behavior remain undefined, particularly in comparison to established peptide-based GLP1RAs.

View Article and Find Full Text PDF

The striatum is divided into two interdigitated tissue compartments, the striosome and matrix. These compartments exhibit distinct anatomical, neurochemical, and pharmacological characteristics and have separable roles in motor and mood functions. Little is known about the functions of these compartments in humans.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!